Loading...
The role of γ-polyglutamic acid in a circular economy: cost-effective production and wide-ranging applications of a bio-derived, biodegradable, and nonimmunogenic biomaterial
Authors
Editors
Other contributors
Epub Date
Issue Date
2025
Submitted date
Alternative
Abstract
Microbial products have long been investigated for their potential as backbones of biodegradable constructs. Poly-γ-glutamic acid (γ-PGA) is an anionic pseudo polypeptide produced by several microorganisms, especially members of the Bacillus species. γ-PGA is synthesised through several enzymes and complexes which racemise and polymerise L- glutamic acid or D- glutamic acid. This non-toxic microbial product can have variable viscosity, is water soluble, biodegradable, and non-immunogenic. The scope of this work was to investigate the effect of substrate components on the chemical and physical characteristics of γ-PGA (Chapter 3). To increase cost-effectiveness and adoption of γ-PGA, further investigation into the effect of different complex media on the yields and composition of resulting material was evaluated (Chapter 3). Subsequently, the potential of γ-PGA from standard cultivation media and complex media as a substitute for hyaluronic acid in cosmetics was evaluated (Chapter 4). UV protective effects of γ-PGA and seaweed rich, crude γ-PGA extracts was assessed and quantified (Chapter 4) and its potential interaction with skin keratinocytes was quantified. γ-PGA ability to interact with ions was assessed in the context of dental demineralisation and prevention thereof (Chapter 5). Potential protein-protein interaction of γ-PGA with monomeric and aggregate forms of alpha synuclein, was assessed in the context of Parkinson disease pathology (Chapter 6). Ultimately the inflammatory response of γ-PGA and γ-PGA-based composites (whey protein isolate- γ-PGA) were also evaluated (Chapter 7). This investigation found the ability of specific ions (Mn2+ and NaCl) to affect the yields and properties of γ-PGA in both standard (GS/Medium E) and complex media (seaweed based). γ-PGA synthesised from complex media could be purified through membrane-based separation technologies although further optimisation is required to selectively removed undesirable impurities. Although commercial γ-PGA was not found to have any UV protection capacity, standard media γ-PGA had some UV protective capacity with complex media derived γ-PGA having the highest protection. No γ-PGA was found to have any detrimental effect on tested HaCaT keratinocyte cells. Both standard and complex media derived γ-PGA did suggest ability to physically bind to components of hydroxyapatite, component of the tooth enamel. Further, our data suggests that γ-PGA is able to co-localise with Parkinson disease specific alpha synuclein aggregates and disrupt further addition of monomeric components onto pre-formed fibrils. In addition, both γ-PGA and pre-formed fibrils of alpha synuclein were shown to be internalised within astrocyte cytoplasm when introduced in the media. Ultimately, γ-PGA addition has shown to significantly decrease inflammatory status of osteoblasts and astrocytes in vitro. This work explores innovative applications of γ-PGA, synthesised from complex media. Fundamental properties of γ-PGA that can be obtained in standard (GS media, Medium E and similar) and complex media have been evaluated for comprehensive understanding on property-application relationship and its potential scale up applications. This work elaborates on how γ-PGA could be the key to the next generation of microbial derived bioproducts.
Citation
Parati, M. (2025) The role of γ-polyglutamic acid in a circular economy: cost-effective production and wide-ranging applications of a bio-derived, biodegradable, and nonimmunogenic biomaterial. University of Wolverhampton. https://wlv.openrepository.com/handle/2436/626059
Publisher
Journal
Research Unit
DOI
PubMed ID
PubMed Central ID
Embedded videos
Additional Links
Type
Thesis or dissertation
Language
en
Description
This thesis is submitted for the degree of Doctor of Philosophy.
Series/Report no.
ISSN
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
The Biotechnology and Biological Sciences Research Council (Swindon, GB), part of grant number: 5749484.
University of Wolverhampton Research Investment Fund (RIF4).
ERDF Science in Industry Research Centre (SIRC 01R19P03464).